STATE STREET CORP - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 26 filers reported holding REGULUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$57,572
-6.1%
41,7190.0%0.00%
Q2 2023$61,327
+73.5%
41,7190.0%0.00%
Q1 2023$35,357
-69.1%
41,719
-50.0%
0.00%
Q4 2022$114,310
+61.0%
83,438
+100.0%
0.00%
Q3 2022$71,000
-17.4%
41,7190.0%0.00%
Q2 2022$86,00041,7190.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 555,555$1,150,0000.31%
Ikarian Capital, LLC 105,341$217,0000.04%
Sarissa Capital Management LP 185,183$383,0000.04%
FEDERATED HERMES, INC. 2,904,826$6,013,0000.02%
Virtu Financial LLC 10,205$21,0000.00%
VICTORY CAPITAL MANAGEMENT INC 221,506$459,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 11,583$24,0000.00%
VANGUARD GROUP INC 372,732$772,0000.00%
UBS Group AG 8,252$17,0000.00%
Community Bank, N.A. 690$1,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders